MOLECULAR RADIATION SCIENCES

Slides:



Advertisements
Similar presentations
Radiologic Imaging Defines the local extent of a tumor Can be used to stage malignant disease Aids in the diagnosis Monitoring tumor changes after treatment.
Advertisements

Post-operative Radiotherapy for Esophageal Cancer Parag Sanghvi, M.D., M.S.P.H. Department of Radiation Medicine Esophageal Care Conference 3/26/2007.
Multidisciplinary approaches on chest tumors Radiation Oncology Case Reports.
TREATMENT PLANNING PHOTONS & ELECTRONS Karen P. Doppke 3/20/2007.
1 ADC Calculations Lars Ewell Radiation Oncology University of Arizona Medical Center 2/8/08 1.
LOCAL CONTROL AMONG YOUNG PATIENTS WITH NON-RHABDOMYOSARCOMA SOFT TISSUE SARCOMA (NRSTS) FOLLOWING RISK-BASED TREATMENT: RESULTS FROM CHILDREN’S ONCOLOGY.
Stereotactic Body Radiation Therapy (SBRT): The optimal indication for operable tumors in inoperable patients D.Katsochi 1, S.Kosmidis 1, A.Fotopoulou.
Thomas F. DeLaney MD, Aashish D. Bhatt MD, Alex Jacobson BS, Richard Y. Lee MD, PhD, Christine Giraud BS, Joseph H. Schwab MD, MS, Francis J. Hornicek.
Radiotherapy Planning for Esophageal Cancers Parag Sanghvi, MD, MSPH 9/12/07 Esophageal Cancer Tumor Board Part 1.
Prof Ramesh S Bilimagga President AROI Group Medical Director - HCG.
بسم الله الرحمن الرحيم و قل رب زدنى علماً ﴿و قل رب زدنى علماً﴾ صدق الله العظيم.
Treatment Guidelines for Pre-operative Radiation Therapy for Retroperitoneal Sarcoma: Preliminary Consensus of an International Expert Panel EH Baldini,
A Phase II Trial of Hippocampal Avoidance During Whole Brain Radiotherapy for Brain Metastases.
Quantitative Dosimetric Analysis Of Patterns Of Local Relapse After IMRT For Primary Extremity Soft Tissue Sarcomas Ryan M. Lanning, Sean L. Berry, Michael.
Image-Guided Adaptive Therapy for the Treatment of Lung Cancer
Irradiation of stem cell niches in the periventricular and sub granular zones in gbm : A Prospective study Akram K S, Monica I, Deepa J, Kesava R, Fayaz.
Adequate 3D Treatment Volume in Preoperative Radiotherapy in Extremity Soft Tissue Sarcoma Kim BK, Chen YL, Kirsch DG, Kobayashi W, Goldberg S, Wolfgang.
3. Results (continued) Of single fraction regimens, 87% prescribed ≥16 Gy. Single fraction treatments were constrained by maximum spinal cord doses of.
Purpose and Objectives: To investigate
SRS for spinal metastases. Who needs surgical stabilization?
Taipei VGH Practice Guidelines: Oncology Guidelines Index Cancer of Lung Version Table of Content StagingStaging, ManuscriptManuscript Taipei Veterans.
Taipei VGH Practice Guidelines: Oncology Guidelines Index Cancer of Oral Cavity Version Table of Content StagingStaging, Manuscript Taipei Veterans.
M ETHODS Median dose was 22Gy (range: ) in 1 to 5 fractions Median treatment volume was 12.6 cc (range: ). Assessed for eligibility.
To investigate the acute toxicity of 3D conformal concurrent chemo RT (Keeping PTV Dmax
Role of Radiation Therapy in Brain metastasis Bongkot Supawongwattana, M.D. Division of Therapeutic Radiology and Oncology, Faculty of Medicine, Chiang.
Head & Neck Ca. (Epithelial tumors) Mohamad KADRI. MD. Clinical oncology. Medical director of AlBerouni University Hospital President of Syrian Association.
第三讲: Basic treatment planning - Dengsong Zhu, MS, DABR Medical Physicist Radiation Safety Officer.
Principles and Practice of Radiation Therapy
 Multidisciplinary Effort › Surgery › Radiation › Systemic Rx (chemo, “drugs”)
SPINAL CORD TUMORS Dr.Ghavam Tavallaee Neurosurgeon.
Patient and Tumour Characteristics Median age 60 years (26-92) Karnofsky Status:median 90 (50-100) Histology:SCC: n=120 (83%) Tumor size: ≥ 5 cm: n=78.
Taipei Veterans General Hospital Practices Guidelines Radiation Oncology Lung Cancer Version
Taipei Veterans General Hospital Practices Guidelines Oncology Rectal Cancer Version
Taipei Veterans General Hospital Practices Guidelines Oncology Oral Cavity Cancer Version
Feifei Teng, Christina I. Tsien, Theodore S. Lawrence, Yue Cao 
Radiotherapy treatment planning and long-term follow-up with [11C]methionine PET in patients with low-grade astrocytoma  Joanne Nuutinen, M.D., Pirkko.
Neuroaxis Radiation for pediatric tumors (Medulloblastoma and Atypical teratoid/rhabdoid tumor) with VMAT (volumetric modulated arc therapy) and IMRT (intensity.
Dirk Vordermark, M. D. , Georg Becker, M. D. , Michael Flentje, M. D
Automatic treatment planning improves the clinical quality of head and neck cancer treatment plans  Christian Rønn Hansen, Anders Bertelsen, Irene Hazell,
Extending intracranial treatment options with Leksell Gamma Knife® Icon™ Key Statements from Customer Perspective by University Medical Centre Mannheim.
Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group  Joachim Yahalom,
The use of 4DCT images to optimize the Internal Target Volume in Radiotherapy  Nikos Giakoumakis, Brian Winey, Joseph Killoran, Tania Lingos, Laurence.
Dosimetric analysis of varying cord planning organ at risk volume in spine stereotactic body radiation therapy  Dawn Owen, MD, PhD, Charles S. Mayo, PhD,
Feasibility of hippocampal sparing radiation therapy for glioblastoma using helical Tomotherapy Dr Kamalram THIPPU JAYAPRAKASH1,2,3, Dr Raj JENA1,4 and.
Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases  Isabelle Thibault, MD, Mikki Campbell,
Pain Control by Image-Guided Radiosurgery for Solitary Spinal Metastasis  Samuel Ryu, MD, Ryan Jin, MD, Jian-Yue Jin, PhD, Qing Chen, PhD, Jack Rock, MD,
Fig. 4. Percentage of passing rate between clinical and 544 plans.
Neuroaxis Radiation for pediatric tumors (Medulloblastoma and Atypical teratoid/rhabdoid tumor) with VMAT (volumetric modulated arc therapy) and IMRT (intensity.
Insert tables Insert graphs Insert figure
Radiotherapy for Metastatic Spinal Cord Compression
מצבי חירום ברפואה אונקולוגית
Modern Treatment Planning
RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1- 3) spine metastases: Phase 2 results  Samuel Ryu, MD, Stephanie L.
Radiation Oncology Department, Bank of Cyprus Oncology Center.
European Urology Oncology
Severe Local Toxicity after Lung Stereotactic Body Radiation Therapy: Lesional Abscess Leading to Bronchocutaneous Fistula Requiring Surgical Marsupialization 
A Multi-Institutional Dosimetric Evaluation of Proton Versus Photon Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma F. Khan, B. Nguyen,
Automatic treatment planning improves the clinical quality of head and neck cancer treatment plans  Christian Rønn Hansen, Anders Bertelsen, Irene Hazell,
Re-irradiation with VMAT for progressive brain metastases after previous whole brain radiation for radionecrosis risk avoidance. Marilena Theodorou, MD.
Case studies: VMAT and SIB (simultaneous integrated boost) in pediatric tumours, from clinical target definition to toxicity as treated in the Radiation.
Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer  Nancy El-Bared, MD,
Technical Advances of Radiation Therapy for Thymic Malignancies
Cone-Beam CT-based position verification for oesophageal cancer: Evaluation of registration methods and anatomical changes during radiotherapy  A. van.
B5-05: Frameless stereotactic body radiotherapy using four dimensional cone beam CT guidance  Jan-Jakob Sonke, Jose Belderbos, Maddalena Rossi, Jochem.
Stereotactic Body Radiation Therapy for the Treatment of Primary Cardiac Angiosarcoma Causing Hemodynamic Instability  Prashant Gabani, MD, Benjamin W.
Todd J. Carpenter, MD, Kenneth E. Rosenzweig, MD 
Metastasen der Wirbelsäule
Fig. 5. Serial follow-up sellar MRIs after treatment
Planning techniques of proton boost
Volumetric and dosimetric comparison of two delineation guidelines for the radiation treatment of laryngeal squamous cell carcinoma  C. Bondue, S. Racadot,
Presentation transcript:

MOLECULAR RADIATION SCIENCES RADIATION ONCOLOGY & MOLECULAR RADIATION SCIENCES Consensus Guidelines for Post-Operative Stereotactic Body Radiation Therapy for Malignant Spine Tumors: Results of an International Survey Kristin J. Redmond, S. Lo, E. Chang, P. Gerszten, S. Chao, L. Rhines, S. Ryu, M. Fehlings, I. Gibbs, A. Sahgal

Contouring guidelines GTV: Post-operative residual based on MRI CTV: Entire extent of pre-operative tumor & anatomic compartment plus residual disease. Hardware and scar not included PTV: Controversial (range 0-2 mm)

Contouring guidelines GTV: Post-operative residual based on MRI CTV: Entire extent of pre-operative tumor & anatomic compartment plus residual disease. Hardware and scar not included PTV: Controversial (range 0-2 mm)

Prescription doses No prior RT, 1 vertebra, no epidural disease: 16-24 Gy x 1 No prior RT, multiple vertebrae or epidural disease: 16-18 Gy x 1, 12 Gy x 2, 8-10 Gy x 3, 6-8 Gy x 5 No prior RT, cord compression: 16-18 Gy x 1, 12 Gy x 2, 8 Gy x 4, 6-7 Gy x 5 Prior RT: 16-18 Gy x 1, 12 Gy x 2, 6-10 Gy x 3, 8-10 Gy x 4, 5-7 Gy x 5

Cord constraints